Insider Trading activities of Invitrogen Corp insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Invitrogen Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Invitrogen Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Invitrogen Corp since 2005. The reporting company's ticker symbol is IVGN. The reporting company's CIK number is 1073431.
The total value of stock buying since 2005 is $3,880,122.
The total value of stock sales since 2005 is $196,970,946.
The total value of stock option exercises since 2005 is $159,543,907.


Go to page:  1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Invitrogen Corp insiders (IVGN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-06-09 Uprichard David C (Director) Option Ex 1,000 33.70 33,695
2010-06-03 Uprichard David C (Director) Sale 1,200 50.71 60,855
2010-06-03 Uprichard David C (Director) Option Ex 1,000 33.70 33,695
2010-06-01 Grossman Paul David (SVP, Corporate Strategy & Dev.) Option Ex 30,000 49.28 1,478,400
2010-05-28 Uprichard David C (Director) Sale 1,000 50.16 50,160
2010-05-28 Uprichard David C (Director) Option Ex 1,000 35.53 35,530
2010-05-27 Uprichard David C (Director) Sale 1,200 50.01 60,012
2010-05-27 Uprichard David C (Director) Option Ex 1,000 35.53 35,530
2010-05-26 Uprichard David C (Director) Sale 1,000 49.18 49,182
2010-05-26 Uprichard David C (Director) Option Ex 1,000 35.53 35,530
2010-05-21 Uprichard David C (Director) Sale 2,000 48.35 96,702
2010-05-21 Uprichard David C (Director) Option Ex 2,000 35.53 71,060
2010-05-18 Miller John L (President, Genetic Systems) Sale 3,098 51.35 159,082
2010-05-17 Brust Bernd (Pres, Commercial Operations) Option Ex 5,500 51.27 281,985
2010-05-17 Miller John L (President, Genetic Systems) Option Ex 5,500 51.27 281,985
2010-05-17 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 5,300 51.27 271,731
2010-05-17 Hoffmeister David F (Chief Financial Officer) Option Ex 5,300 51.27 271,731
2010-05-17 Richard Kelli (Chief Accounting Officer) Option Ex 1,000 51.27 51,270
2010-05-17 Barthelemy Nicolas (President, Cell Systems) Option Ex 5,300 51.27 271,731
2010-05-17 Cottingham John A (Chief Legal Officer) Option Ex 5,300 51.27 271,731
2010-05-13 Uprichard David C (Director) Sale 3,000 52.98 158,943
2010-05-13 Uprichard David C (Director) Option Ex 3,000 36.18 108,540
2010-05-12 Dansky Peter (Pres, Molecular Biology Sys) Sale 6,000 53.00 318,000
2010-05-12 Dansky Peter (Pres, Molecular Biology Sys) Option Ex 6,000 22.23 133,380
2010-05-12 Uprichard David C (Director) Sale 2,000 52.85 105,700
2010-05-12 Uprichard David C (Director) Option Ex 2,000 31.86 63,720
2010-05-07 Dansky Peter (Pres, Molecular Biology Sys) Option Ex 1,300 22.23 28,899
2010-04-29 Barthelemy Nicolas (President, Cell Systems) Sale 14,781 55.00 812,955
2010-04-29 Barthelemy Nicolas (President, Cell Systems) Option Ex 14,500 32.94 477,629
2010-03-16 Miller John L (President, Genetic Systems) Sale 1,148 52.99 60,832
2010-03-16 Barthelemy Nicolas (President, Cell Systems) Sale 924 52.99 48,962
2010-03-16 Lucier Gregory T (Chief Executive Officer) Sale 6,007 52.99 318,310
2010-03-15 Brust Bernd (Pres, Commercial Operations) Option Ex 2,290 53.13 121,667
2010-03-15 Miller John L (President, Genetic Systems) Option Ex 1,814 53.13 96,377
2010-03-15 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 1,616 53.13 85,858
2010-03-15 Hoffmeister David F (Chief Financial Officer) Option Ex 1,830 53.13 97,227
2010-03-15 Barthelemy Nicolas (President, Cell Systems) Sale 16,208 53.00 859,024
2010-03-15 Barthelemy Nicolas (President, Cell Systems) Option Ex 17,822 37.68 671,532
2010-03-15 Lucier Gregory T (Chief Executive Officer) Option Ex 11,266 53.13 598,562
2010-03-15 Uprichard David C (Director) Sale 1,100 52.94 58,182
2010-03-15 Uprichard David C (Director) Option Ex 1,000 36.18 36,180
2010-03-15 Cottingham John A (Chief Legal Officer) Option Ex 1,576 53.13 83,732
2010-03-12 O'donnell Mark Sean (SVP, Global Ops & Services) Sale 30,007 52.66 1,579,874
2010-03-12 O'donnell Mark Sean (SVP, Global Ops & Services) Option Ex 30,007 29.73 892,108
2010-03-11 Beery Joseph C (SVP, Chief Information Officer) Sale 26,444 52.15 1,378,948
2010-03-11 Beery Joseph C (SVP, Chief Information Officer) Option Ex 26,444 32.82 868,024
2010-03-10 Dansky Peter (Pres, Molecular Biology Sys) Sale 6,000 52.18 313,110
2010-03-10 Dansky Peter (Pres, Molecular Biology Sys) Option Ex 6,000 22.23 133,380
2010-03-05 Uprichard David C (Director) Sale 100 52.00 5,200
2010-03-02 Leddy Peter Michael (SVP, Global Human Resources) Sale 679 51.41 34,907
2010-03-02 Barthelemy Nicolas (President, Cell Systems) Sale 1,603 51.41 82,410
2010-03-02 Lucier Gregory T (Chief Executive Officer) Sale 5,077 51.41 261,008
2010-03-02 Uprichard David C (Director) Sale 1,000 52.28 52,275
2010-03-02 Uprichard David C (Director) Option Ex 1,000 36.18 36,180
2010-03-01 Brust Bernd (Pres, Commercial Operations) Sale 11,750 52.01 611,082
2010-03-01 Brust Bernd (Pres, Commercial Operations) Option Ex 11,750 28.30 332,525
2010-03-01 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 1,206 52.00 62,712
2010-03-01 Hoffmeister David F (Chief Financial Officer) Option Ex 3,860 52.00 200,720
2010-03-01 Barthelemy Nicolas (President, Cell Systems) Option Ex 2,652 52.00 137,904
2010-03-01 Lucier Gregory T (Chief Executive Officer) Option Ex 9,522 52.00 495,144
2010-03-01 Cottingham John A (Chief Legal Officer) Option Ex 2,596 52.00 134,992
2010-02-26 Lucier Gregory T (Chief Executive Officer) Option Ex 560,000 50.76 28,425,600
2010-02-26 Uprichard David C (Director) Sale 200 50.83 10,165
2010-02-19 Uprichard David C (Director) Sale 1,000 50.18 50,182
2010-02-19 Uprichard David C (Director) Option Ex 1,000 36.18 36,180
2010-02-18 Uprichard David C (Director) Sale 1,000 49.79 49,790
2010-02-18 Uprichard David C (Director) Option Ex 1,000 36.18 36,180
2010-02-17 Grossman Paul David (SVP, Corporate Strategy & Dev.) Sale 18,556 49.22 913,419
2010-02-17 Grossman Paul David (SVP, Corporate Strategy & Dev.) Option Ex 18,556 22.23 412,499
2010-02-03 Miller John L (President, Genetic Systems) Sale 218 50.15 10,932
2010-02-01 Richard Kelli (Chief Accounting Officer) Option Ex 6,000 49.46 296,760
2010-01-05 Brust Bernd (Pres, Commercial Operations) Option Ex 6,000 52.22 313,320
2009-12-17 Barthelemy Nicolas (President, Cell Systems) Option Ex 5,444 36.80 200,339
2009-12-15 Miller John L (President, Genetic Systems) Sale 19,088 51.62 984,548
2009-12-15 Barthelemy Nicolas (President, Cell Systems) Sale 5,300 52.00 275,600
2009-12-15 Uprichard David C (Director) Sale 600 52.00 31,200
2009-12-15 Cottingham John A (SVP, Chief Legal Officer) Sale 60,000 52.00 3,120,000
2009-12-15 Cottingham John A (SVP, Chief Legal Officer) Option Ex 60,000 31.17 1,870,020
2009-12-14 Uprichard David C (Director) Sale 1,000 51.21 51,210
2009-12-14 Uprichard David C (Director) Option Ex 1,000 36.18 36,180
2009-12-03 Richard Kelli (Chief Accounting Officer) Sale 15,000 50.93 763,905
2009-12-03 Richard Kelli (Chief Accounting Officer) Option Ex 15,000 33.08 496,200
2009-12-01 Miller John L (President, Genetic Systems) Sale 3,533 49.86 176,155
2009-12-01 Uprichard David C (Director) Sale 200 50.85 10,170
2009-11-30 Brust Bernd (Pres, Commercial Operations) Sale 6,250 49.59 309,937
2009-11-30 Brust Bernd (Pres, Commercial Operations) Option Ex 6,250 27.51 171,937
2009-11-23 Brust Bernd (Pres, Commercial Operations) Sale 31,208 49.78 1,554,998
2009-11-23 Brust Bernd (Pres, Commercial Operations) Option Ex 31,208 22.23 693,753
2009-11-23 Barthelemy Nicolas (President, Cell Systems) Sale 15,000 49.90 748,575
2009-11-23 Barthelemy Nicolas (President, Cell Systems) Option Ex 15,000 22.23 333,450
2009-11-18 Leddy Peter Michael (SVP, Global Human Resources) Sale 7,763 50.07 388,693
2009-11-17 Dansky Peter (Pres, Molecular Biology Sys) Sale 20,875 51.12 1,067,088
2009-11-17 Dansky Peter (Pres, Molecular Biology Sys) Option Ex 20,875 39.81 831,033
2009-11-16 Brust Bernd (Pres, Commercial Operations) Sale 2,380 50.38 119,904
2009-11-16 Brust Bernd (Pres, Commercial Operations) Option Ex 2,380 32.26 76,778
2009-11-16 Barthelemy Nicolas (President, Cell Systems) Sale 5,000 50.38 251,900
2009-11-11 Brust Bernd (Pres, Commercial Operations) Sale 14,000 51.00 714,000
2009-11-11 Brust Bernd (Pres, Commercial Operations) Option Ex 14,000 35.87 502,179
2009-11-10 Uprichard David C (Director) Sale 500 50.28 25,137
2009-11-05 Uprichard David C (Director) Sale 700 49.48 34,636
2009-11-04 Uprichard David C (Director) Sale 400 48.28 19,314
2009-11-03 Miller John L (President, Genetic Systems) Sale 585 47.56 27,822
2009-11-03 Uprichard David C (Director) Sale 400 48.04 19,214
2009-09-15 Brust Bernd (Pres, Commercial Operations) Sale 20,164 48.00 967,872
2009-09-15 Brust Bernd (Pres, Commercial Operations) Option Ex 20,164 32.43 653,918
2009-09-14 Hoffmeister David F (SVP, Chief Financial Officer) Sale 192,728 47.49 9,152,652
2009-09-14 Hoffmeister David F (SVP, Chief Financial Officer) Option Ex 192,728 27.50 5,300,020
2009-09-10 O'donnell Mark Sean (SVP, Global Ops & Services) Sale 23,701 46.86 1,110,747
2009-09-10 O'donnell Mark Sean (SVP, Global Ops & Services) Option Ex 23,701 22.62 535,998
2009-09-10 Uprichard David C (Director) Sale 1,000 46.96 46,965
2009-09-10 Uprichard David C (Director) Option Ex 1,000 36.18 36,180
2009-09-09 Grimm Donald W (Director) Sale 20,000 46.66 933,259
2009-09-09 Grimm Donald W (Director) Option Ex 20,000 28.94 578,800
2009-09-08 Uprichard David C (Director) Sale 1,400 46.08 64,512
2009-09-08 Uprichard David C (Director) Option Ex 1,400 36.18 50,652
2009-09-04 Uprichard David C (Director) Sale 2,400 45.42 109,005
2009-09-04 Uprichard David C (Director) Option Ex 2,400 36.18 86,832
2009-09-04 Levine Arnold J (Director) Sale 4,700 45.70 214,790
2009-09-04 Levine Arnold J (Director) Option Ex 5,218 41.09 214,407
2009-07-30 Barthelemy Nicolas (President, Cell Systems) Sale 6,500 47.00 305,500
2009-07-30 Barthelemy Nicolas (President, Cell Systems) Option Ex 6,500 31.26 203,190
2009-07-24 Brust Bernd (Pres, Commercial Operations) Sale 18,000 43.00 774,000
2009-07-24 Brust Bernd (Pres, Commercial Operations) Option Ex 18,000 27.90 502,290
2009-06-04 Leddy Peter Michael (SVP, Global Human Resources) Sale 23,467 40.00 938,680
2009-06-02 Leddy Peter Michael (SVP, Global Human Resources) Sale 300 40.00 12,000
2009-06-02 Barthelemy Nicolas (President, Cell Systems) Sale 3,000 39.90 119,700
2009-05-13 Miller John L (President, Genetic Systems) Sale 4,626 36.50 168,849
2009-05-13 Barthelemy Nicolas (President, Cell Systems) Sale 4,626 36.50 168,849
2009-05-12 Brust Bernd (Pres, Commercial Operations) Option Ex 4,000 .00 0
2009-05-12 Miller John L (President, Genetic Systems) Option Ex 7,200 .00 0
2009-05-12 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 7,200 .00 0
2009-05-12 Hoffmeister David F (SVP, Chief Financial Officer) Option Ex 8,000 .00 0
2009-05-12 Barthelemy Nicolas (President, Cell Systems) Option Ex 7,200 .00 0
2009-05-12 Cottingham John A (SVP, Chief Legal Officer) Option Ex 5,600 .00 0
2009-05-11 Longfield William H (Director) Buy 10,000 36.27 362,700
2009-05-08 Adam George F Jr (Director) Buy 700 36.68 25,678
2009-05-04 Richard Kelli (Chief Accounting Officer) Sale 1,246 36.96 46,045
2009-05-04 Uprichard David C (Director) Sale 1,200 37.10 44,520
2009-05-01 Barthelemy Nicolas (President, Cell Systems) Sale 352 36.45 12,830
2009-04-29 Barthelemy Nicolas (President, Cell Systems) Sale 7,084 35.68 252,721
2009-03-16 Miller John L (President, Genetic Systems) Sale 1,166 29.39 34,268
2009-03-14 Brust Bernd (President, Commercial Ops) Option Ex 2,292 .00 0
2009-03-14 Miller John L (President, Genetic Systems) Option Ex 1,816 .00 0
2009-03-14 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 1,618 .00 0
2009-03-14 Hoffmeister David F (SVP, Chief Financial Officer) Option Ex 1,830 .00 0
2009-03-14 Barthelemy Nicolas (President, Cell Systems) Option Ex 1,616 .00 0
2009-03-14 Lucier Gregory T (Chief Executive Officer) Option Ex 11,266 .00 0
2009-03-14 Cottingham John A (SVP, Chief Legal Officer) Option Ex 1,576 .00 0
2009-03-11 Adam George F Jr (Director) Buy 600 28.01 16,807
2009-02-18 Dansky Peter (Pres, Molecular Biology Sys) Sale 5,455 29.72 162,128
Go to page:  1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of IVGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Invitrogen Corp (symbol IVGN, CIK number 1073431) see the Securities and Exchange Commission (SEC) website.